Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001214659-19-008005
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-26 18:15:06
Reporting Period:
2019-12-23
Accepted Time:
2019-12-26 18:15:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX Pharmaceutical Preparations (2834) 462693615
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599324 Jamie Christensen C/o Mirati Therapeutics, Inc.
9393 Towne Centre Drive, Ste 200
San Diego CA 92121
Evp, Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-23 2,499 $5.50 11,658 No 4 M Direct
Common Stock Disposition 2019-12-23 2,499 $125.00 9,159 No 4 S Direct
Common Stock Acquisiton 2019-12-23 4,167 $5.40 13,326 No 4 M Direct
Common Stock Disposition 2019-12-23 4,167 $125.00 9,159 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-12-23 2,499 $0.00 2,499 $5.50
Common Stock Employee Stock Option (Right to Buy) Disposition 2019-12-23 4,167 $0.00 4,167 $5.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,003 2026-10-26 No 4 M Direct
28,125 2027-01-25 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2018.
  2. Includes 256 shares acquired under the ESPP Purchase on 05/31/2019 and 114 shares acquired under the ESPP purchase on 11/29/2019.
  3. 1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.